BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1279672)

  • 1. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity.
    Barbas CF; Crowe JE; Cababa D; Jones TM; Zebedee SL; Murphy BR; Chanock RM; Burton DR
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10164-8. PubMed ID: 1279672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA libraries.
    Moreno de Alborán I; Martínéz-alonso C; Barbas CF; Burton DR; Ditzel HJ
    Immunotechnology; 1995 May; 1(1):21-8. PubMed ID: 9373330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.
    Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR
    J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.
    Nguyen H; Hay J; Mazzulli T; Gallinger S; Sandhu J; Teng Y; Hozumi N
    Clin Exp Immunol; 2000 Oct; 122(1):85-93. PubMed ID: 11012623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
    Barbas CF; Björling E; Chiodi F; Dunlop N; Cababa D; Jones TM; Zebedee SL; Persson MA; Nara PL; Norrby E
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9339-43. PubMed ID: 1384050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.
    Crowe JE; Firestone CY; Crim R; Beeler JA; Coelingh KL; Barbas CF; Burton DR; Chanock RM; Murphy BR
    Virology; 1998 Dec; 252(2):373-5. PubMed ID: 9878616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
    Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.
    Bourgeois C; Corvaisier C; Bour JB; Kohli E; Pothier P
    J Gen Virol; 1991 May; 72 ( Pt 5)():1051-8. PubMed ID: 2033389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.
    García-Barreno B; Palomo C; Peñas C; Delgado T; Perez-Breña P; Melero JA
    J Virol; 1989 Feb; 63(2):925-32. PubMed ID: 2463385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus.
    Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P
    J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.
    Murphy BR; Olmsted RA; Collins PL; Chanock RM; Prince GA
    J Virol; 1988 Oct; 62(10):3907-10. PubMed ID: 3047432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of kappa light chain contribution to anti-DNA antibody activity of a human VH4-21-encoded monoclonal antibody (NE-1) by antibody-phage display technique.
    Katsube Y; Suzuki H; Muryoi T; Sasaki T
    Int J Mol Med; 1998 May; 1(5):863-8. PubMed ID: 9852308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and preliminary panning of Fab phage display antibody library against respiratory syncytial virus].
    Wang ZH; Zhang GC; Li AM
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):681-5. PubMed ID: 19102829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
    Anderson K; Stott EJ; Wertz GW
    J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.
    Crowe JE; Murphy BR; Chanock RM; Williamson RA; Barbas CF; Burton DR
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1386-90. PubMed ID: 8108420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries.
    Williamson RA; Burioni R; Sanna PP; Partridge LJ; Barbas CF; Burton DR
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4141-5. PubMed ID: 7683424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.
    Bates JT; Keefer CJ; Utley TJ; Correia BE; Schief WR; Crowe JE
    J Immunol; 2013 Apr; 190(7):3732-9. PubMed ID: 23455501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.
    Taylor G; Stott EJ; Furze J; Ford J; Sopp P
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2217-23. PubMed ID: 1383403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.